Medication info
Losartan Plus Tablet

Losartan Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30, 300 tablets/bottle
Approval status
Active

MFDS item code 200700470 · Notified 2007.01.11 · Insurance code 645201200

Summary

Main use
Treatment of hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
○ Adults The usual dose of this medicine is 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg daily are not recommended. The maximum blood pressure-lowering effect generally occurs around 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the expected effect is not achieved with monotherapy. 1. Substitution therapy: This medicine may replace combination therapy with individually titrated losartan potassium and hydrochlorothiazide. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or greater. Administration is not recommended in patients with more severe renal impairment, for whom loop diuretics are preferable to thiazide drugs. ○ Patients with hepatic impairment Administration is not recommended in these patients because the initial dose of losartan potassium of 25 mg required for patients with hepatic impairment who need dose adjustment cannot be administered with this medicine.
Child dose
Under 18 years: Because there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Treatment of hypertension not controlled with monotherapy

  • Hypertension
View approved original text

This medication is used for patients with hypertension who find it difficult to control blood pressure with monotherapy.

How to take

Adult dose

○ Adults The usual dose of this medicine is 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg daily are not recommended. The maximum blood pressure-lowering effect generally occurs around 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the expected effect is not achieved with monotherapy. 1. Substitution therapy: This medicine may replace combination therapy with individually titrated losartan potassium and hydrochlorothiazide. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or greater. Administration is not recommended in patients with more severe renal impairment, for whom loop diuretics are preferable to thiazide drugs. ○ Patients with hepatic impairment Administration is not recommended in these patients because the initial dose of losartan potassium of 25 mg required for patients with hepatic impairment who need dose adjustment cannot be administered with this medicine.

Child dose

Under 18 years: Because there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; it should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to patients with certain allergies or severely impaired kidney function, patients with severe liver disorders, pregnant women or women who may become pregnant, and patients with certain electrolyte imbalances. Caution should be exercised when using this medication in patients with very low blood pressure or abnormalities in renal blood vessels, liver function impairment, systemic lupus erythematosus, elderly patients, etc., as it may increase the risk of skin cancer, and exposure to sunlight should be avoided while regularly monitoring skin conditions. During treatment with this medication, blood pressure, kidney function, and electrolyte levels should be regularly checked for abnormalities, particularly to avoid excessively high or low potassium levels. Some patients may experience side effects such as dizziness, drowsiness, cough, skin rash, abdominal pain, etc.; if symptoms are severe, consult a physician. This medication may interact with other medicines, so if you are taking any other medications, you must inform your healthcare provider, and it is advisable to avoid grapefruit juice. Caution is also needed for women who are breastfeeding, and it is necessary to discuss with your healthcare provider whether to continue taking the medication or to stop breastfeeding. The safety and efficacy of this medication in children and adolescents have not been established, so it is not used in these populations. Dizziness or drowsiness may occur while taking this medication, so caution is required during driving or operating machinery. In case of overdose, symptoms such as hypotension, changes in heart rate may occur, and immediate medical attention should be sought; emergency care will be required. Lastly, keep this medication out of the reach of children, store it in its original container, and do not transfer it to other containers.

Side effects

  • Abdominal pain
  • swelling
  • palpitations
  • back pain
  • dizziness
  • cough
  • sinusitis
  • upper respiratory infection
  • rash
  • angioedema
Show 125 more
  • skin peeling
  • hemolysis
  • chest pain
  • facial swelling
  • fever
  • orthostatic hypotension
  • syncope
  • angina
  • arrhythmia
  • cerebrovascular accident
  • hypotension
  • myocardial infarction
  • secondary atrioventricular block
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • indigestion
  • flatulence
  • gastritis
  • vomiting
  • fatigue
  • anemia
  • gout
  • arm pain
  • joint pain
  • arthritis
  • fibromyalgia
  • hip pain
  • joint swelling
  • knee pain
  • leg pain
  • muscle cramps
  • muscle weakness
  • musculoskeletal pain
  • myalgia
  • shoulder pain
  • muscular rigidity
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • insomnia
  • decreased libido
  • memory impairment
  • migraine
  • neurogenic hypersensitivity
  • panic disorder
  • sensory disturbances
  • peripheral neuropathy
  • sleep disorders
  • drowsiness
  • tremors
  • dyspnea
  • epistaxis
  • nasal congestion
  • pharyngeal discomfort
  • respiratory congestion
  • rhinitis
  • venous sinus disorder
  • chest discomfort
  • alopecia
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • sweating
  • urticaria
  • blurred vision
  • ocular pain
  • burning sensation
  • conjunctivitis
  • vision impairment
  • taste disturbance
  • tinnitus
  • erectile dysfunction
  • nocturia
  • frequency of urination
  • urinary tract infection
  • weakness
  • pancreatitis
  • jaundice
  • sialadenitis
  • seizures
  • gastric irritation
  • aplastic anemia
  • agranulocytosis
  • leukopenia
  • thrombocytopenia
  • purpura
  • necrotizing vasculitis
  • fever
  • pneumonia
  • pulmonary edema
  • acute respiratory distress syndrome
  • hyperglycemia
  • diabetes
  • muscle spasm
  • restlessness
  • renal failure
  • renal dysfunction
  • interstitial nephritis
  • mucocutaneous syndrome
  • erythema multiforme
  • toxic epidermal necrolysis
  • temporary blurred vision
  • xanthopsia
  • acute myopia
  • acute angle-closure glaucoma
  • choroidal exudate
  • vasculitis
  • anaphylactic reaction
  • hepatitis
  • intestinal vascular edema
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a special container that does not allow light to enter. Additionally, it is best to store the medication at room temperature between 1°C and 30°C, avoiding excessively hot or cold areas. This will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.